The Genetic Basis of Panic Disorder
暂无分享,去创建一个
E. Kang | B. Yu | Jae-Hon Lee | Hae-Ran Na
[1] J. Rosenbaum,et al. Behavioral inhibition , 2021, Depression and anxiety.
[2] R. Evershed,et al. Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption , 2010, Neuropsychopharmacology.
[3] J. Rehfeld,et al. Gene variations in the cholecystokinin system in patients with panic disorder , 2010, Psychiatric genetics.
[4] S. Hodge,et al. Association of a Polyadenylation Polymorphism in the Serotonin Transporter and Panic Disorder , 2010, Biological Psychiatry.
[5] S. Hodge,et al. Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR) , 2010, Molecular Psychiatry.
[6] K. Tokunaga,et al. Replication of a genome-wide association study of panic disorder in a Japanese population , 2010, Journal of Human Genetics.
[7] G. Andersson,et al. The symptomatic profile of panic disorder is shaped by the 5-HTTLPR polymorphism , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[8] F. Collins,et al. The HapMap and genome-wide association studies in diagnosis and therapy. , 2009, Annual review of medicine.
[9] Yong-Ku Kim,et al. A Tryptophan Hydroxylase 2 Gene Polymorphism is Associated with Panic Disorder , 2009, Behavior genetics.
[10] Yong-Ku Kim,et al. The association between serotonin-related gene polymorphisms and panic disorder. , 2008, Journal of anxiety disorders.
[11] G. Salum,et al. Harm avoidance and self-directedness as essential features of panic disorder patients. , 2008, Comprehensive psychiatry.
[12] J. Badner,et al. Association between ADORA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety , 2008, Neuropsychopharmacology.
[13] Nikolaos Sakellaridis,et al. Is 472G/A catechol-O-methyl-transferase gene polymorphism related to panic disorder? , 2007, Psychiatric genetics.
[14] J. Smoller,et al. Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. , 2007, Archives of general psychiatry.
[15] G. Salum,et al. Lack of association between the Serotonin Transporter Promoter Polymorphism (5-HTTLPR) and Panic Disorder: a systematic review and meta-analysis , 2007, Behavioral and Brain Functions.
[16] Katharina Domschke,et al. Meta‐analysis of COMT val158met in panic disorder: Ethnic heterogeneity and gender specificity , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[17] E. Maron,et al. Association study of tryptophan hydroxylase 2 gene polymorphisms in panic disorder , 2007, Neuroscience Letters.
[18] J. Woo,et al. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] Fabio Macciardi,et al. Association of the Val158Met Catechol O-Methyltransferase Genetic Polymorphism with Panic Disorder , 2006, Neuropsychopharmacology.
[20] S. Hodge,et al. A Third-Pass Genome Scan in Panic Disorder: Evidence for Multiple Susceptibility Loci , 2006, Biological Psychiatry.
[21] J. Bukszár,et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism , 2006, Molecular Psychiatry.
[22] R. Elston,et al. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. , 2006, American journal of human genetics.
[23] Ayelet Meron Ruscio,et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. , 2006, Archives of general psychiatry.
[24] C. Freitag,et al. Interaction of serotonergic and noradrenergic gene variants in panic disorder , 2006, Psychiatric genetics.
[25] M. Rietschel,et al. The novel brain-specific tryptophan hydroxylase-2 gene in panic disorder , 2006, Journal of psychopharmacology.
[26] K. E. Nichols,et al. Evidence for a Gene-Environment Interaction in Predicting Behavioral Inhibition in Middle Childhood , 2005, Psychological science.
[27] Jerome Kagan,et al. The Corticotropin-Releasing Hormone Gene and Behavioral Inhibition in Children at Risk for Panic Disorder , 2005, Biological Psychiatry.
[28] E. Maron,et al. Associations between serotonin-related gene polymorphisms and panic disorder. , 2005, The international journal of neuropsychopharmacology.
[29] Olga V. Demler,et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[30] C. Zeni,et al. Behaviorial inhibition and history of childhood anxiety disorders in Brazilian adult patients with panic disorder and social anxiety disorder , 2005 .
[31] Michael C Neale,et al. The structure of genetic and environmental risk factors for anxiety disorders in men and women. , 2005, Archives of general psychiatry.
[32] J. Haavik,et al. Different properties of the central and peripheral forms of human tryptophan hydroxylase , 2005, Journal of neurochemistry.
[33] Jerzy Samochowiec,et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum , 2004, Psychiatry Research.
[34] Young-Hee Choi,et al. The association between panic disorder and the L/L genotype of catechol-O-methyltransferase. , 2004, Journal of psychiatric research.
[35] Katharina Domschke,et al. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. , 2004, The international journal of neuropsychopharmacology.
[36] P. Sand,et al. Association Between A2a Receptor Gene Polymorphisms and Caffeine-Induced Anxiety , 2003, Neuropsychopharmacology.
[37] S. Rauch,et al. Inhibited and Uninhibited Infants "Grown Up": Adult Amygdalar Response to Novelty , 2003, Science.
[38] T. Thorgeirsson,et al. Anxiety with panic disorder linked to chromosome 9q in Iceland. , 2003, American journal of human genetics.
[39] N. Norton,et al. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia , 2003, Schizophrenia Research.
[40] J. Akiyoshi,et al. Association between the CCK‐A receptor gene and panic disorder , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[41] S. Higuchi,et al. Association of cholecystokinin-a receptor gene polymorphisms and panic disorder in japanese , 2003 .
[42] S. Hodge,et al. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] B. Yu,et al. Catechol O-methyltransferase genetic polymorphism in panic disorder. , 2002, The American journal of psychiatry.
[44] M C Neale,et al. A review and meta-analysis of the genetic epidemiology of anxiety disorders. , 2001, The American journal of psychiatry.
[45] S. Woods,et al. Linkage genome scan for loci predisposing to panic disorder or agoraphobia. , 2001, American journal of medical genetics.
[46] E. Hattori,et al. Identification of a compound short tandem repeat stretch in the 5′-upstream region of the cholecystokinin gene, and its association with panic disorder but not with schizophrenia , 2001, Molecular Psychiatry.
[47] J. Rosenbaum,et al. Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. , 2001, American journal of medical genetics.
[48] P. Costa,et al. Phobic, panic, and major depressive disorders and the five-factor model of personality. , 2001, The Journal of nervous and mental disease.
[49] R. Wilson,et al. Genomewide survey of panic disorder. , 2001, American journal of medical genetics.
[50] J. Kagan,et al. A controlled study of behavioral inhibition in children of parents with panic disorder and depression. , 2000, The American journal of psychiatry.
[51] S. Hodge,et al. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder , 2000, Molecular Psychiatry.
[52] Steven P. Hamilton,et al. Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22 , 2000, Biological Psychiatry.
[53] S. Hodge,et al. Potential panic disorder syndrome: clinical and genetic linkage evidence. , 2000, American journal of medical genetics.
[54] Kenneth K Kidd,et al. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles , 1999, Biological Psychiatry.
[55] R. Kessler,et al. The economic burden of anxiety disorders in the 1990s. , 1999, The Journal of clinical psychiatry.
[56] J. Vincent,et al. Investigation of cholecystokinin system genes in panic disorder , 1999, Molecular Psychiatry.
[57] M. Nöthen,et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. , 1999, Human molecular genetics.
[58] K. Ohara,et al. No association between anxiety disorders and catechol-O-methyltransferase polymorphism , 1998, Psychiatry Research.
[59] R. Noyes,et al. Possible association of a cholecystokinin promotor polymorphism (CCK-36CT) with panic disorder. , 1998, American journal of medical genetics.
[60] S E Hodge,et al. Results of a genome-wide genetic screen for panic disorder. , 1998, American journal of medical genetics.
[61] H. Mönnikes,et al. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat , 1997, Brain Research.
[62] T. Arinami,et al. An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population , 1997, Psychiatry and clinical neurosciences.
[63] M. Weissman,et al. Familial aggregation and phenomenology of 'early'-onset (at or before age 20 years) panic disorder. , 1997, Archives of general psychiatry.
[64] R. Crowe,et al. Missense mutation of the cholecystokinin B receptor gene: lack of association with panic disorder. , 1996, American journal of medical genetics.
[65] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[66] Streichenwein Sm,et al. Am J Psychiatry , 1996 .
[67] M. Weissman,et al. Is the comorbidity between social phobia and panic disorder due to familial cotransmission or other factors? , 1995, Archives of general psychiatry.
[68] S. Wank,et al. Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse. , 1995, Genomics.
[69] M. Weissman,et al. Psychiatric disorders in relatives of probands with panic disorder and/or major depression. , 1994, Archives of general psychiatry.
[70] T. Yamada,et al. The human gastrin/cholecystokinin type B receptor gene: alternative splice donor site in exon 4 generates two variant mRNAs. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[71] J. Kagan,et al. Behavioral Inhibition in Childhood: A Risk Factor for Anxiety Disorders , 1993 .
[72] J. Rosenbaum,et al. Behavioral inhibition in children: a possible precursor to panic disorder or social phobia. , 1991, The Journal of clinical psychiatry.
[73] J. Kagan,et al. Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. , 1988, Archives of general psychiatry.
[74] E. Harris,et al. Relationship between panic disorder and agoraphobia. A family study. , 1986, Archives of general psychiatry.
[75] J. Vanderhaeghen,et al. New peptide in the vertebrate CNS reacting with antigastrin antibodies , 1975, Nature.
[76] H. S. Davis,et al. A Controlled Study , 1966 .
[77] E. Donaldson,et al. A Family Study. , 1962 .
[78] A. Mack. Childhood history of behavioral inhibition and comorbidity status in 256 adults with social phobia , 2012 .
[79] P. Sullivan,et al. Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype , 2008, Molecular Psychiatry.
[80] N. Schork,et al. Gene-by-Environment (Serotonin Transporter and Childhood Maltreatment) Interaction for Anxiety Sensitivity, an Intermediate Phenotype for Anxiety Disorders , 2008, Neuropsychopharmacology.
[81] N. Wray,et al. Association study of candidate variants of COMT with neuroticism, anxiety and depression , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[82] K. E. Nichols,et al. Behavioral inhibition: linking biology and behavior within a developmental framework. , 2005, Annual review of psychology.
[83] C. Zeni,et al. Behavioral inhibition and history of childhood anxiety disorders in Brazilian adult patients with panic disorder and social anxiety disorder. , 2005, Revista brasileira de psiquiatria.
[84] M. Rietschel,et al. Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. , 2004, Journal of neural transmission. Supplementum.
[85] P. Sullivan,et al. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. , 2002, The American journal of psychiatry.
[86] E. Hattori,et al. Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder , 2001, Journal of Neural Transmission.
[87] S. Hodge,et al. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder , 2001, Molecular Psychiatry.
[88] A. Fyer,et al. The DSM-IV panic disorder field trial: panic attack frequency and functional disability. , 1996, Anxiety.
[89] D. Lichtermann,et al. A controlled family study in panic disorder. , 1993, Journal of psychiatric research.
[90] J. Mendlewicz,et al. Minireview: Molecular genetics in affective illness. , 1993, Life sciences.